Company profile for Biokine

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

While advances in immunotherapy have resulted in remarkable clinical responses in some patients, there will be >14 million new cases of cancer diagnosed in 2020 with >8 million deaths. Resistant and recurrent aggressive metastatic disease is the cause of <90% of these deaths in modern economic societies. Aberrant migration and proliferation of cancer cells are the hallmarks of tumor metastasis and resistant buildup therefore i...
While advances in immunotherapy have resulted in remarkable clinical responses in some patients, there will be >14 million new cases of cancer diagnosed in 2020 with >8 million deaths. Resistant and recurrent aggressive metastatic disease is the cause of <90% of these deaths in modern economic societies. Aberrant migration and proliferation of cancer cells are the hallmarks of tumor metastasis and resistant buildup therefore it is an attractive pathway for anti-cancer modalities.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
Weizmann Science Park PO Box: 2213 Rehovot, 76120
Telephone
Telephone
+972-8-9301-015
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/biokin-having-landed-bms-deal-posts-phase-3-cancer-win-bispecific-adc

FIERCE BIOTECH
03 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty